Effects of an adrenergic beta-receptor blockader, 2-acetyl-7- (2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
1974
ISSN/ISBN: 0015-5691 PMID: 4155394 Document Number: 74868
Document emailed within 1 workday
Related Documents
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Inatomi, N.; Kuriki, H.; Kanno, M.; Kawazoe, K.; Nagawa, Y.; Miyata, T.; Takahama, K.; Kasé, Y. 1980: Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4,-tetrahydro-1-naphthalenol hydrochloride (AA-497), a new potent bronchodilator Arzneimittel-Forschung 30(2): 276-285
Marchetti, G.; Merlo, L.; Noseda, V. 1973: Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601 Bollettino Della Societa Italiana di Cardiologia 18(7): 672-675
Newton, G.E.; Parker, J.D. 1996: Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure Circulation 94(3): 353-358
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Yoshida, T.; Takano, M.; Tamura, A.; Kubota, H.; Suzuki, N. 1970: Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46 Masui. Japanese Journal of Anesthesiology 19(5): 515-522
Feldman, R.D. 1986: Physiological and molecular correlates of age-related changes in the human beta-adrenergic receptor system Federation Proceedings 45(1): 48-50
Actis, E.; Amato, E.A.; Palmero, H.A.; Rebora, E.H.; Fernández Vidal, J.M. 1978: Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients Medicina 38(6 Pt 1): 673-678
Sato, K. 1990: Noradrenaline-induced alterations in beta-adrenergic receptor-adenylate cyclase system of rat myocardium Hokkaido Journal of Medical Science 65(5): 466-473
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Kurennaia, G.S.; Chekneva, E.E.; Grigorian, G.I.; Tkachuk, V.A. 1987: The beta-adrenergic receptor and adenylate cyclase of rat reticulocytes as a test system for screening pharmacologic preparations Biulleten' Eksperimental'noi Biologii i Meditsiny 104(11): 590-594
Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Diekmann, L.; Höhfeld, J. 1971: Effects of adrenergic beta receptor blockaders on centrally caused sympathetic hyperactivity in children Arztliche Forschung 25(10): 335-340